News & Statements
T1International at the United Nations Multi-stakeholder hearing on NCDs and Mental Health
5 May 2025, 7:52 p.m. in News & Statements by T1International
On May 2, 2025, #insulin4all advocates, including T1International’s Executive Director Shaina Kasper, participated in a high-level United Nations hearing to shape the agenda for the upcoming Political Declaration on noncommunicable diseases. In remarks, Kasper called on UN member states to urgently address insulin affordability, support public manufacturing, and center patients in global diabetes policy decisions. Emphasizing that the insulin crisis is far from over, she highlighted patient stories from around the world and urged bold action to ensure equitable access to lifesaving diabetes care. Read more
Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List
9 Apr 2025, 10:04 p.m. in Global Stories, News & Statements by T1International
T1International’s Impact in 2024
3 Mar 2025, 6:26 p.m. in #insulin4all USA, News & Statements by Melissa Passarelli
U.S. Action 2025: Circus of Pharma Greed!
3 Feb 2025, 11:58 p.m. in #insulin4all USA, News & Statements by T1International
T1International's 2025 Strategic Plan
21 Jan 2025, 7:28 p.m. in News & Statements by T1International
Check out T1International's 2025 blog post Read more
T1International Year in Review: 2024
15 Dec 2024, 11:41 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more
Opinion: The insulin crisis is far from over
16 Oct 2024, 6:08 p.m. in #insulin4all USA, News & Statements by Arden Parrish
This blog post was first published in the Hartford Courant on September 15, 2024 by Arden Parrish under the title: Opinion: The insulin crisis is far from over. Public pharma could be the solution. Read more
T1International Announces Leadership Transition: Shaina Kasper Named Executive Director
16 Sep 2024, 10:56 a.m. in News & Statements by T1International
T1International is pleased to announce that Shaina Kasper has been appointed as the new Executive Director. Shaina succeeds Elizabeth “Liz” Pfiester, the organization’s Founder and Executive Director since 2013, who established T1International as a force for change in the fight against insulin price gouging and for the rights of people living with type 1 diabetes. Read more
The movement for public insulin production continues to grow in the United States
12 Jun 2024, 7:40 p.m. in #insulin4all USA, News & Statements by Quinn Nichols, Nicole Koonce, and Allison Hardt
This blog post was first published in Bridge Michigan on May 28, 2024 by Quinn Nichols, Nicole Koonce, and Allison Hardt under the title: Michigan has a chance to learn from California’s public pharma initiative. Read more
World Health Organization and Novo Nordisk Foundation - A Conflict of Interest
29 May 2024, 5:43 p.m. in News & Statements by T1International
T1International and other organisations shared a letter today with Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, urging that the World Health Organization reject any funding directly or indirectly from the pharmaceutical industry. The entity already rejects funding from the tobacco and formula milk industry. The letter also asks WHO to push the pharmaceutical industry to lower prices and create sustainable solutions, and to practise more transparency and accountability to the global community that the entity exists to serve. Read more